• Issue

    European Journal of Haematology: Volume 114, Issue 6

    911-1059
    June 2025
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Free Access

Issue Information

  • Pages: 911-913
  • First Published: 06 May 2025

REVIEW

Free Access

Genetic Mutations Driving Aplastic Anemia: A Focus on Key Allelic Changes

Fabiana Burceaga,  Ayline Cárdenas,  Jessica Ortega,  Eduardo Galván, 
  • Pages: 914-923
  • First Published: 04 March 2025
Free Access

TP53-Mutated Acute Myeloid Leukemia: Review of Treatment and Challenges

Bipin Ghimire,  Markie Zimmer,  Vijayalakshmi Donthireddy, 
  • Pages: 924-937
  • First Published: 04 March 2025
Open Access

Therapeutic Strategies for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia in Adult Patients: Optimizing the Use of Monoclonal Antibodies

Antonella Bruzzese,  Enrica Antonia Martino,  Caterina Labanca,  Giulio Caridà,  Francesco Mendicino,  Eugenio Lucia,  Virginia Olivito,  Noemi Puccio,  Antonino Neri,  Fortunato Morabito,  Ernesto Vigna,  Massimo Gentile, 
  • Pages: 938-952
  • First Published: 06 March 2025
Free Access

Targeting the Immune Microenvironment in Chronic Lymphocytic Leukemia: An Evolving Therapeutic Strategy

Clement Chung,  David Doan, 
  • Pages: 953-972
  • First Published: 11 March 2025

ORIGINAL ARTICLE

Open Access

A Case-Driven Multi-Omics Analysis for Longitudinal Ibrutinib Response Evaluation of Patients With Chronic Lymphocytic Leukemia

Sólja Remisdóttir Veyhe,  Marcus Høy Hansen,  Oriane Cédile,  Michael Boe Møller,  Mie Kiszka Nielsen,  Mads Thomassen,  Karen Juul-Jensen,  Henrik Frederiksen,  Karen Dybkær,  Charlotte Guldborg Nyvold, 
  • Pages: 973-981
  • First Published: 23 February 2025
Open Access

Outcomes of Melflufen Treatment in Patients With Relapsed/Refractory Multiple Myeloma

Shahrier Hossain,  Clifton Mo,  Sarah Patches,  Houry Leblebjian,  Kathryn Goodrich,  Eileen Regan,  Kathleen O'Neill,  Kim Noonan,  Paul G. Richardson,  Jacob Laubach, 
  • Pages: 982-989
  • First Published: 23 February 2025

Improved Outcomes of Myeloma Cast Nephropathy in Newly Diagnosed Multiple Myeloma With Modern Anti-Myeloma Therapies

Michael Sang Hughes,  Metodi Balev,  Jai Radhakrishnan,  Divaya Bhutani,  Markus Mapara,  Suzanne Lentzsch,  Rajshekhar Chakraborty, 
  • Pages: 990-1000
  • First Published: 24 February 2025

Clinical Impact of Continuous Dasatinib Administration on the Prognosis of Patients With BCR::ABL1 Acute Lymphoblastic Leukemia: Result of the Prospective MRD2014 Study Conducted by Fukuoka Blood and Marrow Transplantation Group (FBMTG)

Koji Nagafuji,  Yoshikiyo Ito,  Toshihiro Miyamoto,  Tetsuya Eto,  Tomohiko Kamimura,  Koji Kato,  Yasuhiko Miyazaki,  Atsuhi Wake,  Kentaro Kohno,  Ken Takase,  Yutaka Imamura,  Naoyuki Uchida,  Kazuki Tanimoto,  Noriaki Kawano,  Toshiro Kurokawa,  Yukio Kondo,  Tomoaki Fujisaki,  Junichi Tsukada,  Koji Yonemoto,  Koichi Akashi, 
  • Pages: 1001-1010
  • First Published: 07 March 2025
Open Access

CLLAF SCORE—A New Risk Score for Predicting Atrial Fibrillation in Treatment-Naive CLL Patients Initiating First- and Second-Generation BTK Inhibitor Therapy

Tamar Tadmor,  Guy Melamed,  Hilel Alapi,  Lior Rokach, 
  • Pages: 1011-1019
  • First Published: 12 March 2025
Open Access

Predictive and Prognostic Significance of Patient-Reported Outcomes for Survival and Adverse Events in Daratumumab-Treated Multiple Myeloma

Ahmad Y. Abuhelwa,  Sara A. Almansour,  Ethan Basch,  Humaid O. Al-Shamsi,  Ziad Abuhelwa,  Yasser Bustanji,  Mohammad H. Semreen,  Zelal Kharaba,  Salma M. Ali,  Rawan Mohamed,  Ganessan Kichenadasse,  Ross A. McKinnon,  Michael J. Sorich,  Karem H. Alzoubi,  Ashley M. Hopkins, 
  • Pages: 1020-1031
  • First Published: 14 March 2025

Clinicopathological Prognostic Model for Survival in Adult Patients With Secondary Hemophagocytic Lymphohistiocytosis

Pongthep Vittayawacharin,  Benjamin J. Lee,  Ghayda' E'leimat,  Yen Cao,  Jack Reid,  Ashley Gamayo,  Sherif Rezk,  Elizabeth A. Brem,  Lisa X. Lee,  Piyanuch Kongtim,  Stefan O. Ciurea, 
  • Pages: 1032-1040
  • First Published: 15 March 2025

Genomic Landscape of Mixed Phenotype Acute Leukemia Associated With Immunophenotypic Lineage Predominance: Impact on Diagnosis and Treatment

Ruifang Zheng,  Jeffrey R. Gagan,  Giovanni A. Botten,  Prasad Koduru,  Olga K. Weinberg,  Mingyi Chen,  Miguel D. Cantu,  Jesse Jaso,  Sharon Germans,  Hung S. Luu,  Lina Han,  Tamra L. Slone,  Kathryn E. Dickerson,  Samuel John,  Yazan F. Madanat,  Stephen Chung,  Robert Collins,  Alejandro Marinos,  Franklin Fuda,  Weina Chen, 
  • Pages: 1041-1051
  • First Published: 18 March 2025

LETTER TO THE EDITOR

Measurable Residual Disease in UBTF-TD Adult Acute Myeloid Leukemia

Helena Castellet,  Guillermo Ramil,  Maite Carricondo,  Guadalupe Oñate,  Ana Garrido,  Alícia Artigas,  Marta Pratcorona,  Olga Salamero,  Albert Cortés-Bullich,  Susana Vives,  Mar Tormo,  Martí Mascaró,  David Gallardo,  Josep Maria Marti Tutusaus,  Antonio Garcia,  Jorge Sierra,  Jordi Esteve,  Josep Nomdedéu,  on behalf of the CETLAM group , 
  • Pages: 1052-1054
  • First Published: 23 February 2025

Further Reflections on 6-MP Adherence and Habit Strength: The Impact of Dose Adjustment Complexity and Caregiver Burden

Jiamin Lu,  Hui Wu,  Wei Wei, 
  • Pages: 1055-1056
  • First Published: 07 March 2025

Daratumumab for Posttransplant Autoimmune Hemolytic Anemia

Yaqeen Abduallah,  Michael Kennah,  Connor Prince,  Ashish Masurekar,  Natasha Kekre,  Ram Vasudevan Nampoothiri, 
  • Pages: 1057-1059
  • First Published: 17 March 2025